Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001243439.2(SPECC1):c.281C>G(p.Thr94Arg) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 16/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
SPECC1 (HGNC:30615): (sperm antigen with calponin homology and coiled-coil domains 1) The protein encoded by this gene belongs to the cytospin-A family. It is localized in the nucleus, and highly expressed in testis and some cancer cell lines. A chromosomal translocation involving this gene and platelet-derived growth factor receptor, beta gene (PDGFRB) may be a cause of juvenile myelomonocytic leukemia. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Aug 2011]
Uncertain significance, criteria provided, single submitter
clinical testing
Ambry Genetics
Dec 02, 2021
The c.281C>G (p.T94R) alteration is located in exon 1 (coding exon 1) of the SPECC1 gene. This alteration results from a C to G substitution at nucleotide position 281, causing the threonine (T) at amino acid position 94 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Gain of methylation at T94 (P = 0.0071);Gain of methylation at T94 (P = 0.0071);Gain of methylation at T94 (P = 0.0071);Gain of methylation at T94 (P = 0.0071);Gain of methylation at T94 (P = 0.0071);Gain of methylation at T94 (P = 0.0071);